|
J B Chemicals & Pharmaceuticals has received USFDA approval for Abbreviated New Drug Application (ANDA) for Doxepin Hydrochloride Capsules USP, 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, the generic version of Sinequan (Pfizer), which is indicated for the treatment of anxiety, depression, and other target symptoms of psychoneurosis.
The drug will be manufactured at the company's manufacturing facility at Panoli, Gujarat.
Doxepin Hydrochloride Capsules had an estimated annual sales of
US $23.90 million in the United States (IQVIA MAT Jun' 2023).
|